| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| PDGF-BB | HOT PDB-H4112 | Human PDGF-BB Protein, premium grade | Human | E. coli | ![]() | SDS-PAGE | $180.00 20ug | |
| PDGF-BB | HOTDMF GMP-PDBH19 | GMP Human PDGF-BB Protein | Human | E. coli | ![]() | SDS-PAGE | $885.00 50ug | |
| PDGF-BB | AvitagAIDD‑Ready PDB-H5127 | Unconjugated Human PDGF-BB Protein, His,Avitag™ | Human | E. coli | ![]() | SDS-PAGE | $310.00 50ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Asengeprast | SHP-627; FT-011; FT-11 | Phase 2 Clinical | Fibrotech Therapeutics Pty Ltd, University Of Melbourne | Scleroderma, Diffuse; Scleroderma, Systemic | Details |
| Recombinant Human Platelet-derived Growth Factor B(Lynch Regenerative Medicine) | rhPDGF-BB | Phase 2 Clinical | Lynch Regenerative Medicine LLC | Rectal Fistula | Details |
| REGN-13335 | REGN13335; REGN-13335 | Phase 2 Clinical | Regeneron Pharmaceuticals Inc | Pulmonary Arterial Hypertension | Details |
| HL-217 | HL-217; KR-31831 | Phase 1 Clinical | Korea Research Institute Of Chemical Technology | Macular Degeneration | Details |